{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T05:00:44Z","timestamp":1790312444402,"version":"4.1.0"},"reference-count":53,"publisher":"Elsevier BV","issue":"6","license":[{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"},{"start":{"date-parts":[[2026,6,1]],"date-time":"2026-06-01T00:00:00Z","timestamp":1780272000000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/legal\/tdmrep-license"},{"start":{"date-parts":[[2026,5,26]],"date-time":"2026-05-26T00:00:00Z","timestamp":1779753600000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/creativecommons.org\/licenses\/by\/4.0\/"}],"funder":[{"DOI":"10.13039\/501100002402","name":"Sun Yat-sen University","doi-asserted-by":"publisher","award":["YTP-SYSUCC-0059"],"award-info":[{"award-number":["YTP-SYSUCC-0059"]}],"id":[{"id":"10.13039\/501100002402","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100012152","name":"National Postdoctoral Program for Innovative Talents","doi-asserted-by":"publisher","award":["BX20230446"],"award-info":[{"award-number":["BX20230446"]}],"id":[{"id":"10.13039\/501100012152","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82473139"],"award-info":[{"award-number":["82473139"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82403896"],"award-info":[{"award-number":["82403896"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82373312"],"award-info":[{"award-number":["82373312"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82422061"],"award-info":[{"award-number":["82422061"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100001809","name":"National Natural Science Foundation of China","doi-asserted-by":"publisher","award":["82202855"],"award-info":[{"award-number":["82202855"]}],"id":[{"id":"10.13039\/501100001809","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100004000","name":"Guangzhou Municipal Science and Technology Program key projects","doi-asserted-by":"publisher","award":["2023A04J0518"],"award-info":[{"award-number":["2023A04J0518"]}],"id":[{"id":"10.13039\/501100004000","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100002858","name":"China Postdoctoral Science Foundation","doi-asserted-by":"publisher","award":["2025M772111"],"award-info":[{"award-number":["2025M772111"]}],"id":[{"id":"10.13039\/501100002858","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100021171","name":"Basic and Applied Basic Research Foundation of Guangdong Province","doi-asserted-by":"publisher","award":["2024B1515020114"],"award-info":[{"award-number":["2024B1515020114"]}],"id":[{"id":"10.13039\/501100021171","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["cell.com","elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Cell Reports"],"published-print":{"date-parts":[[2026,6]]},"DOI":"10.1016\/j.celrep.2026.117547","type":"journal-article","created":{"date-parts":[[2026,6,11]],"date-time":"2026-06-11T16:24:44Z","timestamp":1781195084000},"page":"117547","update-policy":"https:\/\/doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":0,"title":["RNF138 promotes cisplatin resistance and PD-L1-mediated immune evasion via JAK2\/STAT3 activation in nasopharyngeal carcinoma"],"prefix":"10.1016","volume":"45","author":[{"given":"Chuyu","family":"He","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Liming","family":"Lou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Lei","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Xianhui","family":"Wen","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Daofeng","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Haibin","family":"Lai","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jiachen","family":"Huang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Lewei","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Qianqian","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jun","family":"Ma","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yelin","family":"Liang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Han","family":"Qiao","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Yuan","family":"Zhang","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"78","reference":[{"key":"10.1016\/j.celrep.2026.117547_bib1","doi-asserted-by":"crossref","first-page":"299","DOI":"10.1038\/s41586-019-1730-1","article-title":"A view on drug resistance in cancer","volume":"575","author":"Vasan","year":"2019","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117547_bib2","doi-asserted-by":"crossref","first-page":"1124","DOI":"10.1056\/NEJMoa1905287","article-title":"Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma","volume":"381","author":"Zhang","year":"2019","journal-title":"N. Engl. J. Med."},{"key":"10.1016\/j.celrep.2026.117547_bib3","doi-asserted-by":"crossref","first-page":"2420","DOI":"10.1200\/JCO.22.00327","article-title":"Final Overall Survival Analysis of Gemcitabine and Cisplatin Induction Chemotherapy in Nasopharyngeal Carcinoma: A Multicenter, Randomized Phase III Trial","volume":"40","author":"Zhang","year":"2022","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117547_bib4","doi-asserted-by":"crossref","first-page":"303","DOI":"10.1016\/S0140-6736(21)01123-5","article-title":"Metronomic capecitabine as adjuvant therapy in locoregionally advanced nasopharyngeal carcinoma: a multicentre, open-label, parallel-group, randomised, controlled, phase 3 trial","volume":"398","author":"Chen","year":"2021","journal-title":"Lancet"},{"key":"10.1016\/j.celrep.2026.117547_bib5","doi-asserted-by":"crossref","first-page":"2","DOI":"10.6004\/jnccn.2025.0007","article-title":"NCCN Guidelines\u00ae Insights: Head and Neck Cancers, Version 2.2025","volume":"23","author":"Colevas","year":"2025","journal-title":"J. Natl. Compr. Canc. Netw."},{"key":"10.1016\/j.celrep.2026.117547_bib6","doi-asserted-by":"crossref","first-page":"840","DOI":"10.1200\/JCO.20.03237","article-title":"Chemotherapy in Combination With Radiotherapy for Definitive-Intent Treatment of Stage II-IVA Nasopharyngeal Carcinoma: CSCO and ASCO Guideline","volume":"39","author":"Chen","year":"2021","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117547_bib7","doi-asserted-by":"crossref","first-page":"452","DOI":"10.1016\/j.annonc.2020.12.007","article-title":"Nasopharyngeal carcinoma: ESMO-EURACAN Clinical Practice Guidelines for diagnosis, treatment and follow-up(\u2020)","volume":"32","author":"Bossi","year":"2021","journal-title":"Ann. Oncol."},{"key":"10.1016\/j.celrep.2026.117547_bib8","doi-asserted-by":"crossref","first-page":"591","DOI":"10.1038\/s41418-020-00708-5","article-title":"Ubiquitination in the regulation of inflammatory cell death and cancer","volume":"28","author":"Cockram","year":"2021","journal-title":"Cell Death Differ."},{"key":"10.1016\/j.celrep.2026.117547_bib9","doi-asserted-by":"crossref","first-page":"148","DOI":"10.1186\/s12943-024-02046-3","article-title":"Ubiquitination and deubiquitination in cancer: from mechanisms to novel therapeutic approaches","volume":"23","author":"Liu","year":"2024","journal-title":"Mol. Cancer"},{"key":"10.1016\/j.celrep.2026.117547_bib10","doi-asserted-by":"crossref","first-page":"58","DOI":"10.1038\/s41392-024-01763-x","article-title":"Suppression of ITPKB degradation by Trim25 confers TMZ resistance in glioblastoma through ROS homeostasis","volume":"9","author":"Yan","year":"2024","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.117547_bib11","doi-asserted-by":"crossref","DOI":"10.1016\/j.drup.2024.101136","article-title":"CBX4 counteracts cellular senescence to desensitize gastric cancer cells to chemotherapy by inducing YAP1 SUMOylation","volume":"77","author":"Gu","year":"2024","journal-title":"Drug Resist. Updat."},{"key":"10.1016\/j.celrep.2026.117547_bib12","doi-asserted-by":"crossref","first-page":"872","DOI":"10.1038\/s41419-025-08140-8","article-title":"TRIM25 degrades BRD7 protein stability through the ubiquitin proteasome pathway to promote breast cancer progression and paclitaxel resistance by activating YB1\/Bcl-2 transcription axis","volume":"16","author":"Xue","year":"2025","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.117547_bib13","doi-asserted-by":"crossref","first-page":"562","DOI":"10.1093\/carcin\/bgad040","article-title":"The ubiquitin E3 ligase MDM2 induces chemoresistance in colorectal cancer by degradation of ING3","volume":"44","author":"Zhang","year":"2023","journal-title":"Carcinogenesis"},{"key":"10.1016\/j.celrep.2026.117547_bib14","doi-asserted-by":"crossref","first-page":"S581","DOI":"10.1016\/j.annonc.2025.08.1516","article-title":"947P First-in-class CBL-B inhibitor NX-1607: Phase Ia data in patients with advanced solid tumors","volume":"36","author":"Williams","year":"2025","journal-title":"Ann. Oncol."},{"issue":"suppl","key":"10.1016\/j.celrep.2026.117547_bib15","doi-asserted-by":"crossref","first-page":"3084","DOI":"10.1200\/JCO.2024.42.16_suppl.3084","article-title":"Safety, pharmacokinetics (PK), pharmacodynamics (PD) and efficacy of KT-253, a targeted protein degrader of MDM2, in patients with relapsed\/refractory (R\/R) solid tumors, lymphoma, high grade myeloid malignancies and acute lymphoblastic leukemia (ALL)","volume":"42","author":"Khawaja","year":"2024","journal-title":"J. Clin. Oncol."},{"key":"10.1016\/j.celrep.2026.117547_bib16","doi-asserted-by":"crossref","first-page":"e72578ff","DOI":"10.1097\/01.HS9.0000967752.72578.ff","article-title":"S210: AN OPEN-LABEL, GLOBAL, PHASE (PH) 1B\/2 STUDY ADDING NAVTEMADLIN (NVTM) TO RUXOLITINIB (RUX) IN PATIENTS (PTS) WITH PRIMARY OR SECONDARY MYELOFIBROSIS (MF) WHO HAVE A SUBOPTIMAL RESPONSE TO RUX","volume":"7","author":"Mascarenhas","year":"2023","journal-title":"HemaSphere"},{"key":"10.1016\/j.celrep.2026.117547_bib17","doi-asserted-by":"crossref","first-page":"1424","DOI":"10.1038\/s41591-023-02369-6","article-title":"The tumor immune microenvironment of nasopharyngeal carcinoma after gemcitabine plus cisplatin treatment","volume":"29","author":"Lv","year":"2023","journal-title":"Nat. Med."},{"key":"10.1016\/j.celrep.2026.117547_bib18","doi-asserted-by":"crossref","first-page":"471","DOI":"10.1093\/jnci\/djaa100","article-title":"A Gene-Expression Predictor for Efficacy of Induction Chemotherapy in Locoregionally Advanced Nasopharyngeal Carcinoma","volume":"113","author":"Lei","year":"2021","journal-title":"J. Natl. Cancer Inst."},{"key":"10.1016\/j.celrep.2026.117547_bib19","doi-asserted-by":"crossref","first-page":"2","DOI":"10.1186\/s43556-024-00239-2","article-title":"Molecular mechanisms and therapeutic strategies in overcoming chemotherapy resistance in cancer","volume":"6","author":"Gu","year":"2025","journal-title":"Mol. Biomed."},{"key":"10.1016\/j.celrep.2026.117547_bib20","doi-asserted-by":"crossref","first-page":"138","DOI":"10.1016\/j.molmed.2020.09.007","article-title":"Predicting and Overcoming Taxane Chemoresistance","volume":"27","author":"Rodrigues-Ferreira","year":"2021","journal-title":"Trends Mol. Med."},{"key":"10.1016\/j.celrep.2026.117547_bib21","doi-asserted-by":"crossref","first-page":"145","DOI":"10.1016\/j.critrevonc.2018.09.017","article-title":"Crosstalk in cancer resistance and metastasis","volume":"132","author":"Norouzi","year":"2018","journal-title":"Crit. Rev. Oncol. Hematol."},{"key":"10.1016\/j.celrep.2026.117547_bib22","doi-asserted-by":"crossref","first-page":"1","DOI":"10.1016\/j.semcancer.2023.10.004","article-title":"TGF-\u03b2, EMT, and resistance to anti-cancer treatment","volume":"97","author":"Wang","year":"2023","journal-title":"Semin. Cancer Biol."},{"key":"10.1016\/j.celrep.2026.117547_bib23","doi-asserted-by":"crossref","DOI":"10.1073\/pnas.2407506121","article-title":"QSOX1 facilitates dormant esophageal cancer stem cells to evade immune elimination via PD-L1 upregulation and CD8 T cell exclusion","volume":"121","author":"Wei","year":"2024","journal-title":"Proc. Natl. Acad. Sci. USA"},{"key":"10.1016\/j.celrep.2026.117547_bib24","doi-asserted-by":"crossref","DOI":"10.1016\/j.intimp.2023.110709","article-title":"STAT3 inhibition enhances gemcitabine sensitivity in pancreatic cancer by suppressing EMT, immune escape and inducing oxidative stress damage","volume":"123","author":"Guo","year":"2023","journal-title":"Int. Immunopharmacol."},{"key":"10.1016\/j.celrep.2026.117547_bib25","doi-asserted-by":"crossref","first-page":"410","DOI":"10.21037\/atm-21-698","article-title":"PIK3CA mutation confers resistance to chemotherapy in triple-negative breast cancer by inhibiting apoptosis and activating the PI3K\/AKT\/mTOR signaling pathway","volume":"9","author":"Hu","year":"2021","journal-title":"Ann. Transl. Med."},{"key":"10.1016\/j.celrep.2026.117547_bib26","doi-asserted-by":"crossref","first-page":"139","DOI":"10.1038\/s41586-023-05940-w","article-title":"PI3K\u03b2 controls immune evasion in PTEN-deficient breast tumours","volume":"617","author":"Bergholz","year":"2023","journal-title":"Nature"},{"key":"10.1016\/j.celrep.2026.117547_bib27","doi-asserted-by":"crossref","DOI":"10.1016\/j.canlet.2022.215970","article-title":"Etomidate elicits anti-tumor capacity by disrupting the JAK2\/STAT3 signaling pathway in hepatocellular carcinoma","volume":"552","author":"Xu","year":"2023","journal-title":"Cancer Lett."},{"key":"10.1016\/j.celrep.2026.117547_bib28","doi-asserted-by":"crossref","first-page":"424","DOI":"10.1038\/s41392-025-02392-8","article-title":"Targeting ubiquitination in disease and therapy","volume":"10","author":"Yang","year":"2025","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.117547_bib29","doi-asserted-by":"crossref","first-page":"399","DOI":"10.1038\/cr.2016.39","article-title":"Ubiquitin modifications","volume":"26","author":"Swatek","year":"2016","journal-title":"Cell Res."},{"key":"10.1016\/j.celrep.2026.117547_bib30","doi-asserted-by":"crossref","first-page":"1446","DOI":"10.1038\/ncb3259","article-title":"The RNF138 E3 ligase displaces Ku to promote DNA end resection and regulate DNA repair pathway choice","volume":"17","author":"Ismail","year":"2015","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117547_bib31","doi-asserted-by":"crossref","first-page":"185","DOI":"10.1038\/s41392-022-00985-1","article-title":"RING finger 138 deregulation distorts NF-\u043aB signaling and facilities colitis switch to aggressive malignancy","volume":"7","author":"Lu","year":"2022","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.117547_bib32","doi-asserted-by":"crossref","first-page":"402","DOI":"10.1038\/s41392-021-00791-1","article-title":"The JAK\/STAT signaling pathway: from bench to clinic","volume":"6","author":"Hu","year":"2021","journal-title":"Signal Transduct. Target. Ther."},{"key":"10.1016\/j.celrep.2026.117547_bib33","doi-asserted-by":"crossref","first-page":"3486","DOI":"10.1038\/s41467-018-05852-8","article-title":"Loss of Wwox drives metastasis in triple-negative breast cancer by JAK2\/STAT3 axis","volume":"9","author":"Chang","year":"2018","journal-title":"Nat. Commun."},{"key":"10.1016\/j.celrep.2026.117547_bib34","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1038\/s41556-024-01349-3","article-title":"SHP-1 inhibition targets leukaemia stem cells to restore immunosurveillance and enhance chemosensitivity by metabolic reprogramming","volume":"26","author":"Xu","year":"2024","journal-title":"Nat. Cell Biol."},{"key":"10.1016\/j.celrep.2026.117547_bib35","doi-asserted-by":"crossref","first-page":"1900","DOI":"10.1136\/gutjnl-2016-313075","article-title":"Tumour-activated neutrophils in gastric cancer foster immune suppression and disease progression through GM-CSF-PD-L1 pathway","volume":"66","author":"Wang","year":"2017","journal-title":"Gut"},{"key":"10.1016\/j.celrep.2026.117547_bib36","doi-asserted-by":"crossref","first-page":"739","DOI":"10.1007\/s00262-006-0272-1","article-title":"Contribution of the PD-L1\/PD-1 pathway to T-cell exhaustion: an update on implications for chronic infections and tumor evasion","volume":"56","author":"Blank","year":"2007","journal-title":"Cancer Immunol. Immunother."},{"key":"10.1016\/j.celrep.2026.117547_bib37","doi-asserted-by":"crossref","first-page":"242","DOI":"10.1186\/s13046-018-0911-3","article-title":"Melanoma cell-secreted exosomal miR-155-5p induce proangiogenic switch of cancer-associated fibroblasts via SOCS1\/JAK2\/STAT3 signaling pathway","volume":"37","author":"Zhou","year":"2018","journal-title":"J. Exp. Clin. Cancer Res."},{"key":"10.1016\/j.celrep.2026.117547_bib38","doi-asserted-by":"crossref","first-page":"1007","DOI":"10.1101\/gad.297135.117","article-title":"CBL family E3 ubiquitin ligases control JAK2 ubiquitination and stability in hematopoietic stem cells and myeloid malignancies","volume":"31","author":"Lv","year":"2017","journal-title":"Genes Dev."},{"key":"10.1016\/j.celrep.2026.117547_bib39","doi-asserted-by":"crossref","first-page":"5701","DOI":"10.1158\/0008-5472.CAN-17-1510","article-title":"Therapeutic Targeting of Oncogenic Tyrosine Phosphatases","volume":"77","author":"Frankson","year":"2017","journal-title":"Cancer Res."},{"key":"10.1016\/j.celrep.2026.117547_bib40","doi-asserted-by":"crossref","DOI":"10.1016\/j.jbc.2024.105709","article-title":"The role of RNF138 in DNA end resection is regulated by ubiquitylation and CDK phosphorylation","volume":"300","author":"Locke","year":"2024","journal-title":"J. Biol. Chem."},{"key":"10.1016\/j.celrep.2026.117547_bib41","doi-asserted-by":"crossref","first-page":"82","DOI":"10.1016\/j.dnarep.2016.04.006","article-title":"RNF138 interacts with RAD51D and is required for DNA interstrand crosslink repair and maintaining chromosome integrity","volume":"42","author":"Yard","year":"2016","journal-title":"DNA Repair"},{"key":"10.1016\/j.celrep.2026.117547_bib42","article-title":"DDAH1 Promotes Cisplatin Chemoresistance in Patients with Locally Advanced Nasopharyngeal Carcinoma via the EGFR-JAK2-STAT3 Pathway","volume":"12","author":"Yang","year":"2025","journal-title":"Adv. Sci. (Weinh.)"},{"key":"10.1016\/j.celrep.2026.117547_bib43","doi-asserted-by":"crossref","DOI":"10.1016\/j.cyto.2021.155595","article-title":"Acylglycerol kinase promotes paclitaxel resistance in nasopharyngeal carcinoma cells by regulating FOXM1 via the JAK2\/STAT3 pathway","volume":"148","author":"Zhao","year":"2021","journal-title":"Cytokine"},{"key":"10.1016\/j.celrep.2026.117547_bib44","doi-asserted-by":"crossref","first-page":"772","DOI":"10.1038\/s41419-021-04042-7","article-title":"Gemcitabine and APG-1252, a novel small molecule inhibitor of BCL-2\/BCL-XL, display a synergistic antitumor effect in nasopharyngeal carcinoma through the JAK-2\/STAT3\/MCL-1 signaling pathway","volume":"12","author":"Luo","year":"2021","journal-title":"Cell Death Dis."},{"key":"10.1016\/j.celrep.2026.117547_bib45","doi-asserted-by":"crossref","first-page":"6344","DOI":"10.1002\/cam4.2501","article-title":"RIG-I promotes IFN\/JAK2 expression and the endoplasmic reticulum stress response to inhibit chemoradiation resistance in nasopharyngeal carcinoma","volume":"8","author":"Jing","year":"2019","journal-title":"Cancer Med."},{"key":"10.1016\/j.celrep.2026.117547_bib46","doi-asserted-by":"crossref","DOI":"10.1016\/j.bbadis.2025.167948","article-title":"Role of the CEACAM7-JAK2\/STAT3-BST2 Axis in the migration of ` cells","volume":"1871","author":"Li","year":"2025","journal-title":"Biochim. Biophys. Acta. Mol. Basis Dis."},{"key":"10.1016\/j.celrep.2026.117547_bib47","doi-asserted-by":"crossref","first-page":"94","DOI":"10.7150\/ijbs.85341","article-title":"G3BP1 Interact with JAK2 mRNA to Promote the Malignant Progression of Nasopharyngeal Carcinoma via Activating JAK2\/STAT3 Signaling Pathway","volume":"20","author":"Zhan","year":"2024","journal-title":"Int. J. Biol. Sci."},{"key":"10.1016\/j.celrep.2026.117547_bib48","doi-asserted-by":"crossref","first-page":"269","DOI":"10.1016\/j.phymed.2018.05.007","article-title":"Ovatodiolide suppresses nasopharyngeal cancer by targeting stem cell-like population, inducing apoptosis, inhibiting EMT and dysregulating JAK\/STAT signaling pathway","volume":"56","author":"Liu","year":"2019","journal-title":"Phytomedicine"},{"key":"10.1016\/j.celrep.2026.117547_bib49","doi-asserted-by":"crossref","first-page":"1653","DOI":"10.1126\/science.1071545","article-title":"A road map for those who don't know JAK-STAT","volume":"296","author":"Aaronson","year":"2002","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117547_bib50","doi-asserted-by":"crossref","DOI":"10.1126\/science.adf1329","article-title":"Combined JAK inhibition and PD-1 immunotherapy for non-small cell lung cancer patients","volume":"384","author":"Mathew","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117547_bib51","doi-asserted-by":"crossref","DOI":"10.1126\/science.ade8520","article-title":"JAK inhibition enhances checkpoint blockade immunotherapy in patients with Hodgkin lymphoma","volume":"384","author":"Zak","year":"2024","journal-title":"Science"},{"key":"10.1016\/j.celrep.2026.117547_bib52","doi-asserted-by":"crossref","first-page":"5214","DOI":"10.1039\/D2CS00193D","article-title":"PROTACs: past, present and future","volume":"51","author":"Li","year":"2022","journal-title":"Chem. Soc. Rev."},{"key":"10.1016\/j.celrep.2026.117547_bib53","doi-asserted-by":"crossref","first-page":"99","DOI":"10.1186\/s12943-021-01434-3","article-title":"Proteolysis-targeting chimeras (PROTACs) in cancer therapy","volume":"21","author":"Li","year":"2022","journal-title":"Mol. Cancer"}],"container-title":["Cell Reports"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472600625X?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S221112472600625X?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2026,9,25]],"date-time":"2026-09-25T04:39:06Z","timestamp":1790311146000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S221112472600625X"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2026,6]]},"references-count":53,"journal-issue":{"issue":"6","published-print":{"date-parts":[[2026,6]]}},"alternative-id":["S221112472600625X"],"URL":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117547","relation":{},"ISSN":["2211-1247"],"issn-type":[{"value":"2211-1247","type":"print"}],"subject":[],"published":{"date-parts":[[2026,6]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"RNF138 promotes cisplatin resistance and PD-L1-mediated immune evasion via JAK2\/STAT3 activation in nasopharyngeal carcinoma","name":"articletitle","label":"Article Title"},{"value":"Cell Reports","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.celrep.2026.117547","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"\u00a9 2026 The Authors. Published by Elsevier Inc.","name":"copyright","label":"Copyright"}],"article-number":"117547"}}